Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on August 4, 2026

Aug. 4, 2026

Borderless Tech Launches Space Pick, an Interactive Floor Plan Booking Platform, as It Expands into Hong Kong, Canada, and North America

Indeterminate GlobeNewswire

Aug. 4, 2026

CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®

Indeterminate GlobeNewswire

Aug. 4, 2026

3D Systems Announces CEO Transition Plan

Indeterminate GlobeNewswire

Aug. 4, 2026

Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile

Indeterminate GlobeNewswire

Aug. 4, 2026

Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement

Indeterminate GlobeNewswire

Aug. 4, 2026

Microchip Technology, in Collaboration With Micron Technology, Demonstrates High-Performance PCIe® Gen 6 Storage Architecture for AI and Data Center Infrastructure

Indeterminate GlobeNewswire

Aug. 4, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire

Aug. 4, 2026

Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Oblenio Announces First Patients Dosed in Innovative Phase 1a Trial of LBL-051 in Refractory Autoimmune Diseases

Indeterminate GlobeNewswire

Aug. 4, 2026

Remix Therapeutics to Present at 46th Annual Canaccord Genuity Growth Conference

Indeterminate GlobeNewswire

Aug. 4, 2026

Descartes Sets Date to Announce Second Quarter Fiscal 2027 Financial Results

Indeterminate GlobeNewswire

Aug. 4, 2026

Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 4, 2026

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Indeterminate GlobeNewswire

Aug. 4, 2026

iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer

Indeterminate GlobeNewswire

Aug. 4, 2026

Shoals Technologies Group, Inc. Reports Financial Results for Second Quarter 2026

Indeterminate GlobeNewswire

Aug. 4, 2026

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Indeterminate GlobeNewswire

Aug. 4, 2026

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Indeterminate GlobeNewswire

Aug. 4, 2026

Aeluma Names Jason Taylor Senior Director of Program and Project Management

Indeterminate GlobeNewswire

Aug. 4, 2026

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire